Nothing Special   »   [go: up one dir, main page]

YU283173A - Improved process for the isolation of cephalosporin c - Google Patents

Improved process for the isolation of cephalosporin c

Info

Publication number
YU283173A
YU283173A YU02831/73A YU283173A YU283173A YU 283173 A YU283173 A YU 283173A YU 02831/73 A YU02831/73 A YU 02831/73A YU 283173 A YU283173 A YU 283173A YU 283173 A YU283173 A YU 283173A
Authority
YU
Yugoslavia
Prior art keywords
cephalosporin
isolation
improved process
improved
Prior art date
Application number
YU02831/73A
Other languages
English (en)
Inventor
B G Jackson
M C Stamper
E M Bottorff
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00306130A external-priority patent/US3843642A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of YU283173A publication Critical patent/YU283173A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/12Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
YU02831/73A 1972-11-13 1973-10-31 Improved process for the isolation of cephalosporin c YU283173A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US00306130A US3843642A (en) 1972-11-13 1972-11-13 Cephalosporin c derivatives
US00398725A US3853863A (en) 1972-11-13 1973-09-19 Cephalosporin c isolation process

Publications (1)

Publication Number Publication Date
YU283173A true YU283173A (en) 1982-02-28

Family

ID=26974991

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02831/73A YU283173A (en) 1972-11-13 1973-10-31 Improved process for the isolation of cephalosporin c

Country Status (24)

Country Link
US (1) US3853863A (fr)
JP (1) JPS5721318B2 (fr)
KR (1) KR780000012B1 (fr)
AR (1) AR202466A1 (fr)
AT (1) AT327386B (fr)
AU (1) AU471843B2 (fr)
CA (1) CA1016163A (fr)
CH (1) CH599224A5 (fr)
CS (1) CS192506B2 (fr)
DD (1) DD112653A5 (fr)
DE (1) DE2356122C2 (fr)
ES (1) ES420336A1 (fr)
FR (1) FR2207140B1 (fr)
GB (1) GB1444575A (fr)
HU (1) HU167596B (fr)
IE (1) IE38382B1 (fr)
IL (1) IL43560A (fr)
NL (1) NL180106C (fr)
PH (1) PH9509A (fr)
PL (1) PL91577B1 (fr)
RO (1) RO63260A (fr)
SE (1) SE409713B (fr)
SU (1) SU603343A3 (fr)
YU (1) YU283173A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2458554A1 (de) * 1974-01-03 1975-07-10 Lepetit Spa Neues verfahren fuer die gewinnung von cephalosporin c aus einer fermentationsbruehe
GB1489231A (en) * 1974-02-20 1977-10-19 Alfa Farmaceutici Spa Process for the recovery of cephalosporin c and derivatives thereof
JPS557438B2 (fr) * 1974-02-22 1980-02-25
US4168268A (en) * 1977-03-01 1979-09-18 Merck & Co., Inc. Process for isolating thienamycin
US4137405A (en) * 1977-07-28 1979-01-30 Merck & Co., Inc. Isolation of antibiotic Cephamycin C
FR2404642A1 (fr) * 1977-09-29 1979-04-27 Roussel Uclaf Nouveau derive de la cephalosporine c, procede de preparation et application du nouveau produit a la preparation de l'acide 7-amino cephalosporanique
AT367060B (de) * 1979-01-25 1982-05-25 Biochemie Gmbh Verfahren zur herstellung neuer cephalosporinderivate
JPS58143751A (ja) * 1982-02-19 1983-08-26 日本電熱株式会社 排便装置付ベツト
US5512454A (en) * 1994-02-03 1996-04-30 Bristol-Myers Squibb Company Enzymatic acylation of 3-hydroxymethyl cephalosporins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3227709A (en) * 1961-11-28 1966-01-04 Merck & Co Inc Derivatives of cephalosporin c and process
US3234222A (en) * 1962-02-16 1966-02-08 Ciba Geigy Corp Preparation of 7-acylaminocephalosporanic acids
CH481142A (de) * 1966-12-05 1969-11-15 Ciba Geigy Verfahren zur Isolierung von Cephalosporin C
GB1311268A (en) * 1971-01-26 1973-03-28 Pfizer Process for the isolation of n-benzoyl cephalosporin c

Also Published As

Publication number Publication date
AU6155573A (en) 1975-04-24
DE2356122A1 (de) 1974-05-22
IL43560A (en) 1976-09-30
PL91577B1 (fr) 1977-03-31
IE38382L (en) 1974-05-13
AT327386B (de) 1976-01-26
NL180106B (nl) 1986-08-01
CS192506B2 (en) 1979-08-31
FR2207140B1 (fr) 1977-06-03
ES420336A1 (es) 1976-06-16
AU471843B2 (en) 1976-05-06
JPS5721318B2 (fr) 1982-05-06
NL180106C (nl) 1987-01-02
IE38382B1 (en) 1978-03-01
DD112653A5 (fr) 1975-04-20
SE409713B (sv) 1979-09-03
ATA954273A (de) 1975-04-15
PH9509A (en) 1976-01-09
NL7315480A (fr) 1974-05-15
SU603343A3 (ru) 1978-04-15
HU167596B (fr) 1975-11-28
AR202466A1 (es) 1975-06-13
JPS49133595A (fr) 1974-12-21
FR2207140A1 (fr) 1974-06-14
GB1444575A (en) 1976-08-04
CH599224A5 (fr) 1978-05-12
KR780000012B1 (en) 1978-03-04
DE2356122C2 (de) 1983-12-22
CA1016163A (fr) 1977-08-23
RO63260A (fr) 1978-06-15
US3853863A (en) 1974-12-10
IL43560A0 (en) 1974-03-14

Similar Documents

Publication Publication Date Title
YU129573A (en) Process for the determination of cholesterine
CH614188A5 (en) Process for the preparation of novel aminophenylethanolamines
ATA392073A (de) Verbindungsvorrichtung zur losbaren befestigung eines tragbalkens an einem steher
IL39382A0 (en) Process for the preparation of cephalosporin
EG10850A (en) Process for the preparation of 1-hydroxy-pyridones
YU283173A (en) Improved process for the isolation of cephalosporin c
YU310373A (en) Process for obtaining alfa-aminoacyl cephalosporins
ZA737697B (en) Process for the preparation of thiazolesulphenamides
EG11434A (en) Process for the manufacture of n-benzhydryl-n-p-hydroxybenzyl-piperazines
HK62977A (en) Process for the manufacture of triacetone-amine
ZA73320B (en) Process for preparing primary 3-carbamoyloxymethyl cephalosporins
YU108273A (en) Process for obtaining cephalosporin
YU121973A (en) Process for obtaining silylesters of azetidine-2-sulfenate
CH614430A5 (en) Process for the preparation of substituted phenylguanidines
GB1407917A (en) Process for the preparation of thiazolesulphenamides
ZA731178B (en) Process for the preparation of alpha-6-deoxytetracyclines
GB1405791A (en) Process for the preparation of pyridoindolobenzazepines
KR780000135B1 (en) Process for the preparation of oxazolidines
YU19073A (en) Process for the manufacture of cyanoalkylaminopropanes
GB1406113A (en) Process for the preparation of cephalosporin estets
YU36035B (en) Process for the manufacture of cephalosporin derivatives
GB1405218A (en) Process for the manufacture of 2-aryl-v-triazoles
GB1403686A (en) Process for the preparation of azines
ZA738046B (en) Improved cephalosporin c isolation process and intermediate compounds therefor
GB1405709A (en) Process for the preparation of alkyl benzimidazolyl-carbamates